ArticleJournal of inorganic biochemistry2026
When the wrong metal stops the cycle: Dynamics and specificity in plant copper-dependent peptide cyclases.
Article in Journal of inorganic biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Emerging classes of copper enzymes.Current opinion in chemical biology · 2026Review
- Biosynthesis of 14-Membered Cyclopeptide Alkaloids via Nonheme Iron- and 2-Oxoglutarate-Dependent Oxidative Decarboxylation.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Herein, we report the expression of split BURP domain peptide cyclases (BpCs), primarily CamB1 from Ceanothus americanus, in Escherichia coli using the pET22b vector without a fusion partner while retaining their disordered N-terminal region. To our knowledge, this represents the first full-length split BpC expressed and isolated without reliance on a stabilizing fusion tag (e.g., maltose binding protein, MBP). Both CamB1 and ArbB2, from Coffea arabica, were purified and refolded from inclusion bodies, and displayed robust catalytic turnover on a minimal peptide substrate. Copper titrations revealed that catalytic assays using glutathione as the reducing agent require copper far in excess of the stoichiometric number of active sites, with activity plateauing at ∼50-fold excess, likely reflecting competition with nonspecific copper binding or solution speciation. Using ascorbic acid in place of glutathione not only restores but also increases maximal activity, requiring only near-stochiometric copper. Metal impact studies demonstrated that noncognate metals inhibit activity. Zn(II) most severely inhibited BpC function at low micromolar concentrations in enzyme-initiated assays containing Cu(II), Zn(II), and glutathione, but this effect was markedly alleviated in reducing agent-initiated assays and instead resembled the modest inhibition by Ag(I), which fully suppressed activity only near 1 mM. These results highlight how assay order influences metal competition at the active site. Given that BURP-domain proteins are implicated in plant stress responses, including tolerance to metal exposure, these findings suggest that Zn(II) and Ag(I) inhibition may represent a biochemical mechanism by which environmental metal stress modulates BpC activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.